Skip to main content
Clinical Trials/NL-OMON51322
NL-OMON51322
Recruiting
Not Applicable

Study about clinical characteristics and molecular markers of carcinosarcoma of the uterus - CUS II

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Female patients older than 18 year who are diagnosed with a histologically
  • confirmed CSU. Patients will be asked to sign informed consent.
  • Patients are also able to choose if they want to participate in a part of the
  • study (molecular analysis, registration of clinical outcomes and/or
  • participation in quality of life questionnaires). Patients who are already
  • included for the CUS\-study can for additionally join the CUS II study for the
  • molecular analysis.

Exclusion Criteria

  • Patients who are not able to fill in the questionnaires due to language (Dutch)
  • or who are not mentally competent are excluded for the part of quality of life.

Outcomes

Primary Outcomes

Not specified

Similar Trials